Literature DB >> 8631962

Granulocyte-macrophage colony-stimulating factor stimulates JAK2 signaling pathway and rapidly activates p93fes, STAT1 p91, and STAT3 p92 in polymorphonuclear leukocytes.

M F Brizzi1, M G Aronica, A Rosso, G P Bagnara, Y Yarden, L Pegoraro.   

Abstract

Granulocyte-macrophage colony-stimulating factor (GM-CSF), supports proliferation, differentiation, and functional activation of hemopoietic cells by its interaction with a heterodimeric receptor. Although GM-CSF receptor is devoid of tyrosine kinase enzymatic activity, GM-CSF-induced peripheral blood polymorphonuclear leukocytes (PMN) functional activation is mediated by the phosphorylation of a large number of intracellular signaling molecules. We have previously shown that JAK2 becomes tyrosine-phosphorylated in response to GM-CSF in PMN. In the present study we demonstrate that also the signal transducers and activators of transcription (STAT) family members STAT1 p91 and STAT3 p92 and the product of the c-fps/fes protooncogene become tyrosine-phosphorylated upon GM-CSF stimulation and physically associated with both GM-CSF receptor beta common subunit and JAK2. Moreover GM-CSF was able to induce JAK2 and p93fes catalytic activity. We also demonstrate that the association of the GM-CSF receptor beta common subunit with JAK2 is ligand-dependent. Finally we demonstrate that GM-CSF induces a DNA-binding complex that contains both p91 and p92. These results identify a new signal transduction pathway activated by GM-CSF and provide a mechanism for rapid activation of gene expression in GM-CSF-stimulated PMN.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8631962     DOI: 10.1074/jbc.271.7.3562

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Activated Fes protein tyrosine kinase induces terminal macrophage differentiation of myeloid progenitors (U937 cells) and activation of the transcription factor PU.1.

Authors:  Jynho Kim; Ricardo A Feldman
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

2.  Responsiveness of human neutrophils to interleukin-4: induction of cytoskeletal rearrangements, de novo protein synthesis and delay of apoptosis.

Authors:  D Girard; R Paquin; A D Beaulieu
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

3.  Constitutive MHC class I molecules negatively regulate TLR-triggered inflammatory responses via the Fps-SHP-2 pathway.

Authors:  Sheng Xu; Xingguang Liu; Yan Bao; Xuhui Zhu; Chaofeng Han; Peng Zhang; Xuemin Zhang; Weihua Li; Xuetao Cao
Journal:  Nat Immunol       Date:  2012-04-22       Impact factor: 25.606

4.  Secretion of MIP-1β and MIP-1α by CD8(+) T-lymphocytes correlates with HIV-1 inhibition independent of coreceptor usage.

Authors:  Kevin O Saunders; Cavin Ward-Caviness; Robert J Schutte; Stephanie A Freel; R Glenn Overman; Nathan M Thielman; Coleen K Cunningham; Thomas B Kepler; Georgia D Tomaras
Journal:  Cell Immunol       Date:  2010-10-27       Impact factor: 4.868

5.  GM-CSF action in the CNS decreases food intake and body weight.

Authors:  Jacquelyn A Reed; Deborah J Clegg; Kathleen Blake Smith; Emeline G Tolod-Richer; Emily K Matter; Lara S Picard; Randy J Seeley
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

6.  The KRAB-associated co-repressor KAP-1 is a coiled-coil binding partner, substrate and activator of the c-Fes protein tyrosine kinase.

Authors:  Frank J Delfino; Jonathan M Shaffer; Thomas E Smithgall
Journal:  Biochem J       Date:  2006-10-01       Impact factor: 3.857

Review 7.  Advances in the Development of Janus Kinase Inhibitors in Inflammatory Bowel Disease: Future Prospects.

Authors:  Mathurin Flamant; Josselin Rigaill; Stephane Paul; Xavier Roblin
Journal:  Drugs       Date:  2017-07       Impact factor: 9.546

8.  Autophagy promotes radiation-induced senescence but inhibits bystander effects in human breast cancer cells.

Authors:  Yao-Huei Huang; Pei-Ming Yang; Qiu-Yu Chuah; Yi-Jang Lee; Yi-Fen Hsieh; Chih-Wen Peng; Shu-Jun Chiu
Journal:  Autophagy       Date:  2014-04-30       Impact factor: 16.016

Review 9.  Prospect of JAK2 inhibitor therapy in myeloproliferative neoplasms.

Authors:  Ehab Atallah; Srdan Verstovsek
Journal:  Expert Rev Anticancer Ther       Date:  2009-05       Impact factor: 4.512

10.  Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis.

Authors:  Debra M Meyer; Michael I Jesson; Xiong Li; Mollisa M Elrick; Christie L Funckes-Shippy; James D Warner; Cindy J Gross; Martin E Dowty; Shashi K Ramaiah; Jeffrey L Hirsch; Matthew J Saabye; Jennifer L Barks; Nandini Kishore; Dale L Morris
Journal:  J Inflamm (Lond)       Date:  2010-08-11       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.